-
Cancer Grand Challenges announces global research funding opportunity with nine new challenges
Wed, Mar 08 2023
As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
-
NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
Wed, Dec 28 2022
A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.
-
Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health
Wed, Dec 14 2022
A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.
